Bromiset 0.8 Tablet contains Bromocriptine 0.8 mg, a dopamine agonist medicine used in the management of various endocrine, neurological, and hormonal disorders. The medicine works by stimulating dopamine receptors in the brain, helping regulate the secretion of certain hormones and influencing neurological pathways involved in disease management. It is prescribed under medical supervision for conditions where modulation of dopamine activity provides therapeutic benefits.

Bromocriptine helps reduce elevated prolactin levels by suppressing prolactin secretion from the pituitary gland. This action makes it useful in the treatment of hyperprolactinemia and related conditions. The medicine may also be utilized in selected neurological disorders, including Parkinsonian syndromes, where dopamine receptor stimulation helps support symptom control. Its unique mechanism of action provides therapeutic value across multiple medical specialties.

The tablet is commonly prescribed for hyperprolactinemia, prolactin-secreting pituitary disorders, menstrual disturbances associated with elevated prolactin levels, infertility related to hyperprolactinemia, and selected neurological conditions as determined by a healthcare professional. Regular treatment may help restore hormonal balance, improve symptom management, and support overall patient well-being when used according to medical advice.

With the increasing recognition and diagnosis of endocrine and neurological disorders, Bromiset 0.8 Tablet continues to maintain relevance in the specialty pharmaceutical segment. Its established therapeutic utility, physician acceptance, and broad clinical applications contribute to steady market demand. The product offers valuable business opportunities and sustainable growth potential for retailers and distributors operating within the endocrinology and specialty care sectors.

Bromiset 0.8 Tablet may cause nausea, vomiting, dizziness, headache, fatigue, abdominal discomfort, constipation, low blood pressure, or nasal congestion. Some individuals may experience confusion, hallucinations, or other neurological effects that require medical attention.

Bromiset 0.8 Tablet is indicated for hyperprolactinemia, prolactin-secreting pituitary disorders, menstrual disturbances associated with elevated prolactin levels, infertility related to hyperprolactinemia, Parkinsonian disorders, and other conditions as advised by a healthcare professional.

This medication should be used only under the supervision of a qualified healthcare professional. Patients should follow the prescribed dosage and attend regular follow-up appointments as advised. Individuals with cardiovascular disease, psychiatric disorders, liver impairment, or other significant medical conditions should inform their physician before starting treatment. Sudden discontinuation should be avoided unless specifically recommended by a healthcare professional.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children. Do not use after the expiry date or if the packaging is damaged, opened, or shows signs of tampering.